ALS Better Care Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The ALS Better Care Act (H.R. 5663) is a legislative proposal introduced in the 118th Congress aimed at improving care for individuals with Amyotrophic Lateral Sclerosis (ALS). The bill was referred to the House Subcommittee on Health but has since failed or expired without further legislative action. Specific provisions, funding mechanisms, or detailed policy measures are not available in the provided data.
H.R. 5663 sought to enhance care for ALS patients but did not advance beyond subcommittee referral and ultimately failed or expired in the 118th Congress.
- The bill is focused on the health policy area, specifically targeting care improvements for ALS patients.
- It was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health.
- No official summary or full text is available, limiting detailed understanding of its provisions.
['Individuals diagnosed with ALS', 'Healthcare providers specializing in ALS care', 'Health agencies involved in ALS patient support and treatment']
['Lack of publicly available detailed bill text and summary limits assessment of implementation challenges.', 'Unclear funding sources or budgetary impact due to missing financial details.', 'Absence of information on oversight or enforcement provisions may affect accountability.']
The bill was introduced during the 118th Congress and referred to the House Subcommittee on Health. It did not progress beyond this stage and was ultimately classified as failed or expired. The lack of further legislative action suggests limited congressional movement on this specific proposal within the session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased demand for specialized ALS healthcare services if provisions were enacted.', 'Possible influence on future ALS-related health policy proposals by raising awareness of care needs.', "Impact on healthcare resource allocation depending on the bill's unprovided funding and program details."]
The absence of an official summary and full bill text restricts comprehensive analysis and public transparency. This lack of information complicates oversight and informed discussion by stakeholders. Additionally, the bill's failure to advance beyond subcommittee referral limits the availability of legislative history or amendments that could clarify its scope and impact.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.